1 Need for 7-day/24-hour ABPM interpreted chronobiologically: consensus Dedicated to Prof. Franz Halberg, Dr. M.D., Dr. h.c. multi Jarmila Siegelova, Jiri.

Slides:



Advertisements
Similar presentations
Adel E. Berbari, MD, FAHA, FACP Professor of Medicine and Physiology Head, Division of Hypertension and Vascular Medicine American University of Beirut-
Advertisements

1 Mark Huffman, MD, MPH Northwestern University Feinberg School of Medicine Northwestern Memorial Hospital Healthy Transitions 21 November 2013 Blood Pressure.
G.N. Dalekos3, M. Elisaf2, A.I. Hatzitolios1
EVERYTHING YOU WANTED TO KNOW ABOUT IT BUT DID NOT DARE TO ASK ABPM (Ambulatory Blood Pressure Monitoring)
Valsartan Antihypertensive Long-Term Use Evaluation Results
LONG TERM BLOOD PRESSURE MONITORING J. Dušek 1, B. Fišer 1, J. Siegelová 1, P. Vank 1, G. Cornelissen 2, F. Halberg 2 1 Masaryk University, Brno 2 Halberg.
CME Program for Family Physicians Ambulatory BP Monitoring Brian Gore, MD CCFP Dip Epid. CME Program for Family Physicians Ambulatory BP Monitoring Brian.
Rimoldi SF et al. J Clin Hypertens (Greenwich). 2015;17(3): Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive.
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Blood Pressure and Heart Rate Chapter 3. What is Blood Pressure The force exerted by the blood on the walls of the arteries (and veins) as the blood is.
The Effect of Coffee Anjelice Foreman, Nellie Campa, Myia Rainey, Jackie Davis.
DynaPulse Non-invasive Blood pressure and Hemodynamic Monitoring Example Applications: Cardiac Rhythm & Hypertension Managements Pulse.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Dr. Mehdi Reza Emadzadeh Department of cardiology Mashhad University of Medical Science.
DECREASING SLEEP-TIME BLOOD PRESSURE DETERMINED BY AMBULATORY MONITORING REDUCES CARDIOVASCULAR RISK Ramón C. Hermida, PhD; Diana E. Ayala, MD, MPH, PhD;
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Ambulatory blood pressure as a predictor of cardiovascular risk: What’s new?
Review Breast Cancer Screening Public Comment (CMS #125) and Discuss Controlling High Blood Pressure Measure Updates (CMS #165) Change Review Process Meeting.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Comparison of Blood Pressure Lowering with Hydrochlorothiazide and Chlorthalidone Kurt A. Wargo, Pharm.D., BCPS, Thomas M. English, Ph.D., Anna J. Aaron,
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
DynaPulse Non-invasive Blood pressure and Hemodynamic Monitoring Example Applications: Cardiac Rhythm & Hypertension Managements Pulse.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
PWV & PWA Parameter Extraction / Transfer Function.
AMBULATORY BLOOD PRESSURE MONITORING HEALTH WATCH IN BRNO, CZECH REPUBLIC Homolka P., Siegelová J., Cornélissen G.*, Fišer B., Dušek J., Vank P., Mašek.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
The Phoenix Project Usage – Germaine Cornélissen © 2007 Germaine G Cornelissen-Guillaume. Copying and distribution of this document is permitted in any.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
2007 Hypertension as a Public Health Risk January, 2007.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
December 02 1 Vascular mortality: Age-specific hazard ratios for 20 mmHg lower usual SBP deaths at ages
Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.
Are the European Practice Guidelines for the Management of Arterial Hypertension (2007) adapted to the old and the frail? Anette Hylen
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Community Teaching Project: Hypertension Presented by: Mariel Alvarez, Michelle Vickers, Andy Nguyen, Lalita Poon, Minh Luong.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Carditech, California, USA University Of West Bohemia, Czech Republic
Management of Hypertension according to JNC 7
Dr John Cox Diabetes in Primary Care Conference Cork
Blood Pressure Hypertension Orthostatics
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
Blood Pressure and Age in Controlling Hypertension
From ESH 2016 | POS 7D: Jan Rosa, MD
Health and Human Services National Heart, Lung, and Blood Institute
Copyright © 2011 American Medical Association. All rights reserved.
What’s New in the 2013 ESC/ESH Hypertension Guideline
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
White-coat Hypertension
Copyright © 2007 American Medical Association. All rights reserved.
United States Preventive Services Task Force: Recommendations for ABPM
Systolic Blood Pressure Intervention Trial (SPRINT)
Progress and Promise in RAAS Blockade
Hypertension Guidelines
Prehypertensive and Other Variabilities Also Await Treatment
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Primary Hypertension Max C. Reif, M.D.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Factors Influencing Human Blood Pressure and Heart Rate in Clinical Health Germaine Cornelissen1, Kuniaki Otsuka2, Yoshihiko Watanabe3, Jarmila Siegelova4,
Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.
Presentation transcript:

1 Need for 7-day/24-hour ABPM interpreted chronobiologically: consensus Dedicated to Prof. Franz Halberg, Dr. M.D., Dr. h.c. multi Jarmila Siegelova, Jiri Dusek, Pavel Homolka, Jarmila Siegelova, Jiri Dusek, Pavel Homolka, Dept. of Physiotherapy and Rehabilitation and Department of Functional Diagnostics and Rehabilitation, Masaryk University Brno, St. Anna Faculty Hospital Brno, Czech Republic

In our recent 7-day ambulatory blood pressure monitoring study we described the relationship between age and MESOR of systolic blood pressure (SBP) and diastolic blood pressure (DBP) in heathy subjects (n=84)

 MESOR - mean values of systolic SBP and DBP were increasing with age up to 75 years.

Comparison between casual blood pressure measurements and 7-day blood pressure monitoring

Our results clearly indicate the advantage of the long term blood pressure monitoring over casual blood pressure measurement for the blood pressure evaluation.

 Evaluation of blood pressure amplitude of circadian cycle by 7-day ambulatory blood pressure ambulatory monitoring

 Double amplitude of SBP and DBP reached the maximum value at 45 years and then decreased (Hypertension 2006).

 Forty patients after myocardial infarction (IM) treated with beta-blockers, Ca-antagonists and ACE-inhibitors (age between 41 and 77 years, mean age 61 years) were compared with 44 healthy controls (C, age between 40 and 77 years, mean age 54 years). TREATED PATIENTS WITH ISCHEMIC HEART DISEASE

 A significant increase of SBP MESOR with age was found in C (r=0.39, p<0.01), but not in IM (r=0.23).  Mean value of SBP MESOR was higher in C than in IM (128±9 vs. 121±8 mmHg, p<0.01), as well as DBP MESOR (81±7 vs. 74±7 mmHg, p<0.01).  Decrease of DBP with age in IM was observed (r=0.362, p<0.05).

 Double amplitude SBP decreased with age in C (r=0.30, p<0.05) but not in IM (r=0.03).  Similarly double amplitude DBP decreased with age in C (r=0.41, p<0.01) and not in IM (r=0.08).  Mean values of double amplitude were lower in IM (DA SBP: 21±10 vs. 16±8 mmHg, p<0.01; double amplitude DBP: 16±8 vs. 12±5 mmHg, p<0.01). Heart rate (HR) was not age related in both groups, difference in mean values of HR was not observed (C: 71±10, IM: 65±8 bpm).  Double amplitude HR was lower in IM (15±8 vs. 9±5 bpm).

 This decline of double amplitude was not seen in our patients with heart disease. Furthermore double amplitude in about 50 years old treated patients was lower than in our about 50 years of age controls. This fact is positive because excessive circadian double amplitude (CHAT) is accompanied with an increased risk for morbidity and mortality.

BRNO CONSENSUS

Extended consensus on need and means to detect vascular variability disorders (VVDs) and vascular variability syndromes (VVSs) F. Halberg, G. Cornélissen, K. Otsuka, J. Siegelova, B. Fiser, J. Dusek, P. Homolka, S.Sanches de la Pena, R.B. Singh and the BIOCOS project

Given that conventional health care practice is concerned mainly with high blood pressure (BP), and given the fact that other variability disorders – circadian overswing, excesive pulse pressure, odd circadian BP timing and deficient heart rate (HR) variability (in their own right or in combination with MESOR – hypertension) – are not diagnosed but contribute to cardiovascular disease risk, we wanted to find out 1. how many patients escape current diagnosis (and treatment), and 2. what are the risks such patients incur.

Thank you for the attention. Support: MSM